Endogenex, Inc. — Form D
Endogenex, Inc. of PLYMOUTH, MN, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-17. The offering totals $18.3M, of which $18.3M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-10-17
- Form: D
- Accession: 0001567619-23-007503
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $18.3M
- Amount sold: $18.3M
- Investors: 9
- Date of first sale: 2023-10-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-495020
Issuer
- Name: Endogenex, Inc.
- CIK: 0001730881
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 151 CHESHIRE LANE N, SUITE 400, PLYMOUTH, MN, 55441
- Phone: (651) 341-3805
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| John Deedrick | Director | Plymouth, MN |
| James Eadie, M.D. | Director | Plymouth, MN |
| James Eadie | Director | Arden Hills, MN |
| Juliet Bakker | Director | Malvern, PA |
| Robert Kukuljan | Executive Officer | Minneapolis, MN |
| Gerald Brunk | Director | Plymouth, MN |
| Stacey Pugh | Director | Plymouth, MN |
| Stacey Pugh | Executive Officer | Plymouth, MN |
| Jeffrey Terrell | Director | Durham, NC |
| John Deedrick | Executive Officer | Plymouth, MN |
| ROBERT KUKUJLAN | Executive Officer | PLYMOUTH, MN |
| PAUL HINDRICHS | Director | Plymouth, MN |
| PAUL HINDRICHS | Executive Officer | Plymouth, MN |
| Michael Brenzel | Executive Officer | St. Paul, MN |
Other filings by this issuer (5)
More